Behavioral Health Providers

Treating Tranq: Practical Lessons from the Epicenter of the Xylazine Crisis

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses how to identify and treat xylazine-associated wounds with patient-centered strategies.This didactic case-based session addresses national xylazine trends, drug properties, overdose and withdrawal management, wound care, pain management, and harm reduction with a focus on patient-centered care.

Wounds, Withdrawal, and Overdose: What to Expect from Xylazine Drug Supply Adulteration

This 75-minute on-demand session from the ASAM 54th Annual Conference addresses the pharmacology, toxicology, diagnostic testing, and epidemiology of xylazine in exposures. The session includes didactic content, case-based narrative, review of literature, and panel discussion to review important topics about the emerging xylazine crisis in the US.

Meaningfully Partnering With Harm Reduction Organizations and Other Community-based Organizations That Serve People Who Use Drugs

This tool highlights another valuable method for health departments to ensure the inclusion of People With Lived or Living Experience (PWLLE): establishing grantmaking programs and developing meaningful partnerships with community-based organizations (CBOs) that are led for and by PWLLE, including harm reduction organizations. The target audience for this tool includes all staff within substance use-related departments.